Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justyna Piekielna

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Postepy Biochemii|May 14, 2013
[Salvinorin A and related diterpenes--biological activity and potential therapeutic uses]Justyna Piekielna, Jakub Fichna, Anna Janecka
Current Medicinal Chemistry|May 7, 2019
Biased Agonism as an Emerging Strategy in the Search for Better Opioid AnalgesicsJustyna Piekielna-Ciesielska, Karol Wtorek, Anna Janecka
Peptides|February 15, 2014
Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometryJustyna Piekielna, Alicja Kluczyk, Renata Perlikowska, et al.
Current Drug Targets|April 30, 2013
Cyclization in opioid peptidesJustyna Piekielna, Renata Perlikowska, Katarzyna Gach, et al.
Peptides|April 29, 2023
Corrigendum to "Cyclopeptide Dmt-[D-Lys-p-CF<sub>3</sub>-Phe-Phe-Asp]NH<sub>2</sub>, a novel G protein-biased agonist of the mu opioid receptor" [Peptides 101 (2018) 227-233]Justyna Piekielna-Ciesielska, Federica Ferrari, Girolamo Calo', et al.
Peptides|June 5, 2020
The search for opioid analgesics with limited tolerance liabilityKarol Wtorek, Justyna Piekielna-Ciesielska, Tomasz Janecki, et al.
Peptides|December 3, 2017
Cyclopeptide Dmt-[D-Lys-p-CF<sub>3</sub>-Phe-Phe-Asp]NH<sub>2</sub>, a novel G protein-biased agonist of the mu opioid receptorJustyna Piekielna-Ciesielska, Federica Ferrari, Girolamo Calo', et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 20, 2025
Non-invasive pharmacological profiling of novel endomorphin-2 analogs by confocal Raman spectroscopy and imagingJakub Maciej Surmacki, Julia Mroczkowska, Katarzyna Gach-Janczak, et al.
Chemmedchem|May 16, 2020
Pharmacological Profile and Molecular Modeling of Cyclic Opioid Analogues Incorporating Various Phenylalanine DerivativesAnna Adamska-Bartłomiejczyk, Piotr F J Lipiński, Justyna Piekielna-Ciesielska, et al.
Molecules (Basel, Switzerland)|September 10, 2021
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist PeptidomimeticsCharlène Gadais, Justyna Piekielna-Ciesielska, Jolien De Neve, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Postepy Biochemii|May 14, 2013
[Salvinorin A and related diterpenes--biological activity and potential therapeutic uses]Justyna Piekielna, Jakub Fichna, Anna Janecka
Current Medicinal Chemistry|May 7, 2019
Biased Agonism as an Emerging Strategy in the Search for Better Opioid AnalgesicsJustyna Piekielna-Ciesielska, Karol Wtorek, Anna Janecka
Peptides|February 15, 2014
Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometryJustyna Piekielna, Alicja Kluczyk, Renata Perlikowska, et al.
Current Drug Targets|April 30, 2013
Cyclization in opioid peptidesJustyna Piekielna, Renata Perlikowska, Katarzyna Gach, et al.
Peptides|April 29, 2023
Corrigendum to "Cyclopeptide Dmt-[D-Lys-p-CF<sub>3</sub>-Phe-Phe-Asp]NH<sub>2</sub>, a novel G protein-biased agonist of the mu opioid receptor" [Peptides 101 (2018) 227-233]Justyna Piekielna-Ciesielska, Federica Ferrari, Girolamo Calo', et al.
Peptides|June 5, 2020
The search for opioid analgesics with limited tolerance liabilityKarol Wtorek, Justyna Piekielna-Ciesielska, Tomasz Janecki, et al.
Peptides|December 3, 2017
Cyclopeptide Dmt-[D-Lys-p-CF<sub>3</sub>-Phe-Phe-Asp]NH<sub>2</sub>, a novel G protein-biased agonist of the mu opioid receptorJustyna Piekielna-Ciesielska, Federica Ferrari, Girolamo Calo', et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 20, 2025
Non-invasive pharmacological profiling of novel endomorphin-2 analogs by confocal Raman spectroscopy and imagingJakub Maciej Surmacki, Julia Mroczkowska, Katarzyna Gach-Janczak, et al.
Chemmedchem|May 16, 2020
Pharmacological Profile and Molecular Modeling of Cyclic Opioid Analogues Incorporating Various Phenylalanine DerivativesAnna Adamska-Bartłomiejczyk, Piotr F J Lipiński, Justyna Piekielna-Ciesielska, et al.
Molecules (Basel, Switzerland)|September 10, 2021
Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist PeptidomimeticsCharlène Gadais, Justyna Piekielna-Ciesielska, Jolien De Neve, et al.
Pageof 4